Osteoporosis: Clinical sciences

4,339views

Osteoporosis: Clinical sciences

Watch later

Watch later

Attention deficit hyperactivity disorder (ADHD): Clinical sciences
Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): Clinical sciences
Alcohol use disorder: Clinical sciences
Alcohol withdrawal: Clinical sciences
Selective serotonin reuptake inhibitors
Atypical antidepressants
Monoamine oxidase inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Atypical antipsychotics
Typical antipsychotics
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Psychomotor stimulants
Malaria: Clinical sciences
Sickle cell disease: Clinical sciences
Multiple myeloma: Clinical sciences
Zika virus
Dengue virus
Human T-lymphotropic virus
Trichuris trichiura (Whipworm)
Ancylostoma duodenale and Necator americanus
Babesia
Plasmodium species (Malaria)
Diphyllobothrium latum
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Antimalarials
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Dyslipidemia: Clinical sciences
Congestive heart failure: Clinical sciences
Infectious endocarditis: Clinical sciences
Cardiovascular disease screening: Clinical sciences
Deep vein thrombosis: Clinical sciences
Vasculitis: Pathology review
Adrenergic antagonists: Beta blockers
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Lipid-lowering medications: Fibrates
Lipid-lowering medications: Statins
Miscellaneous lipid-lowering medications
Pheochromocytoma: Clinical sciences
Adrenal insufficiency: Clinical sciences
Primary aldosteronism (hyperaldosteronism): Clinical sciences
Multiple endocrine neoplasia: Clinical sciences
Hyperparathyroidism: Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Neuroendocrine tumors of the gastrointestinal system: Pathology review
Hypopituitarism: Pathology review
Pituitary tumors: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism medications
Alcohol-induced hepatitis: Clinical sciences
Cirrhosis: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Acute pancreatitis: Clinical sciences
Pilonidal disease: Clinical sciences
Hemorrhoids: Clinical sciences
Perianal abscess and fistula: Clinical sciences
Anal fissure: Clinical sciences
Appendicitis: Clinical sciences
Diverticulitis: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Gastritis: Clinical sciences
Peptic ulcer disease: Clinical sciences
Stress ulcers: Clinical sciences
Celiac disease: Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Infectious gastroenteritis: Clinical sciences
Esophageal cancer: Clinical sciences
Anal cancer: Clinical sciences
Colorectal cancer: Clinical sciences
Gastric cancer: Clinical sciences
Femoral hernias: Clinical sciences
Umbilical hernias: Clinical sciences
Inguinal hernias: Clinical sciences
Helicobacter pylori
Vibrio cholerae (Cholera)
Colorectal polyps and cancer: Pathology review
Acid reducing medications
Antidiarrheals
Hepatitis medications
Laxatives and cathartics
Well-patient care (adult): Clinical sciences
Well-patient care (GYN): Clinical sciences
Breast cancer screening: Clinical sciences
Carotid artery stenosis screening: Clinical sciences
Cervical cancer screening: Clinical sciences
Colorectal cancer screening: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Skin cancer screening: Clinical sciences
Anaphylaxis: Clinical sciences
Glucocorticoids
Non-corticosteroid immunosuppressants and immunotherapies
Hemochromatosis: Clinical sciences
Henoch-Schonlein purpura: Clinical sciences
Systemic lupus erythematosus: Clinical sciences
Reactive arthritis: Clinical sciences
Temporal arteritis: Clinical sciences
Systemic sclerosis (scleroderma): Clinical sciences
Infectious mononucleosis: Clinical sciences
Lyme disease: Clinical sciences
Burns: Clinical sciences
Hypothermia: Clinical sciences
Yellow fever virus
Seronegative and septic arthritis: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Fat-soluble vitamin deficiency and toxicity: Pathology review
Water-soluble vitamin deficiency and toxicity: B9, B12 and vitamin C: Pathology review
Zinc deficiency and protein-energy malnutrition: Pathology review
Environmental and chemical toxicities: Pathology review
Antimetabolites: Sulfonamides and trimethoprim
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Azoles
Anthelmintic medications
Herpesvirus medications
Osteoporosis: Clinical sciences
Mechanical back pain: Clinical sciences
Gout: Clinical sciences
Calcium pyrophosphate deposition disease (pseudogout): Clinical sciences
Osteoarthritis: Clinical sciences
Inflammatory myopathies: Clinical sciences
Osteomyelitis: Clinical sciences
Septic arthritis: Clinical sciences
Compartment syndrome: Clinical sciences
Anatomy clinical correlates: Bones, joints and muscles of the back
Anatomy clinical correlates: Knee
Anatomy clinical correlates: Leg and ankle
Antigout medications
Osteoporosis medications
Subarachnoid hemorrhage: Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Multiple sclerosis: Clinical sciences
Myasthenia gravis: Clinical sciences
West Nile virus
Adult brain tumors: Pathology review
Local anesthetics
Migraine medications
Adrenergic antagonists: Alpha blockers
Medications for neurodegenerative diseases
Preconception care: Clinical sciences
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Cytomegalovirus (CMV), parvovirus B19, varicella zoster, and toxoplasmosis infection in pregnancy: Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Herpes simplex virus infection in pregnancy: Clinical sciences
Anemia in pregnancy: Clinical sciences
Early pregnancy loss: Clinical sciences
Ectopic pregnancy: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Therapeutic and induced abortions: Clinical sciences
Asthma in pregnancy: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Estrogens and antiestrogens
Progestins and antiprogestins
Lower urinary tract infection: Clinical sciences
Pyelonephritis: Clinical sciences
Approach to acute kidney injury: Clinical sciences
Chronic kidney disease: Clinical sciences
Nephrolithiasis: Clinical sciences
BK virus (Hemorrhagic cystitis)
Fibroadenoma: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Breast papilloma: Clinical sciences
Infertility: Clinical sciences
Uterine leiomyoma: Clinical sciences
Perimenopause, menopause, and primary ovarian insufficiency: Clinical sciences
Benign prostatic hypertrophy and prostate cancer: Clinical sciences
Testicular cancer: Clinical sciences
Benign breast conditions: Pathology review
Penile conditions: Pathology review
PDE5 inhibitors
Asthma: Clinical sciences
Sleep apnea: Clinical sciences
Coxiella burnetii (Q fever)
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Antihistamines for allergies
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Benign skin lesions: Clinical sciences
Chest X-ray interpretation: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Osteoporosis is a metabolic bone disease characterized by low bone density, decreased bone mass, and increased risk of fracture.

Osteoporosis can be either primary or secondary. Primary osteoporosis is more common in postmenopausal patients, and it refers to bone loss that occurs with aging due to low levels of sex hormones, namely estrogen. Low estrogen levels cause increased osteoclastic activity, and since osteoclasts break down bone, this means increased bone resorption and, as a consequence, low bone density.

Secondary osteoporosis, on the other hand, occurs because of an underlying cause, typically a medical condition, like rheumatoid arthritis, or a side effect of medications like glucocorticoids, especially when used for long periods of time. Osteoporosis is typically diagnosed using a dual-energy X-ray absorptiometry or DXA scan, and sometimes a FRAX score.

Now, most patients with osteoporosis are asymptomatic, so perform a focused history and physical exam. When obtaining history, important risk factors include being postmenopausal, fracture history without major trauma, low BMI less than 20 kg/m2, osteopenia on imaging, a family history of osteoporosis or parental hip fracture, a history of smoking or excessive alcohol use, as well as medical conditions like rheumatoid arthritis, or the use of medications like long-term glucocorticoids.

Finally, regardless of risk factors, you should screen all biological females over 65, biological males over 70, and individuals who are 5 years postmenopause for osteoporosis. Additionally, physical exam findings might reveal skeletal deformities, such as kyphosis or loss of height.

Ok, now, if you suspect osteoporosis based on the patient’s risk factors and physical exam, the next step is ordering a DXA scan, which tests a patient’s bone mineral density. A DXA scan is typically performed at the hip and lumbar spine level. In patients with either known or suspected hyperparathyroidism a DXA scan of the distal third of the radius can be considered, as in these patients, bone loss tends to occur faster in the radius.

Alright, now lets look at the possible results of our DXA scan. DXA scan results are typically reported as a T-score, which is a standard deviation measure of a patient’s bone density compared to a reference population. Ok, now, a T-score greater than or equal to -1.0 is normal. In other words, there’s no osteoporosis and you can consider alternate diagnosis.

On the other hand, if the T-score is between -1.0 and -2.5, then the patient may have either osteopenia or osteoporosis, so you should use the Fracture Risk Assessment Tool to calculate a FRAX score.

The FRAX score estimates a person's 10-year risk of either a hip fracture, or a major osteoporotic fracture based on their age, sex, weight, height, and history of personal or parental fracture. It also takes into account smoking status, alcohol use, glucocorticoid use, history of rheumatoid arthritis, and bone mineral density at the femoral neck.

If the FRAX score shows that the patient’s 10-year risk is less than 3% for hip fracture, and less than 20% for major fracture, then your patient has osteopenia. If this is the case, you should encourage lifestyle modifications, such as increased dietary calcium intake, alongside vitamin D supplementation. Next, counsel your patient on smoking cessation, limiting alcohol intake, as well as weight-bearing, balance, and resistance exercises. If the patient is at increased risk of falling, you should refer them to a physical therapist.

However, if the FRAX score reveals a 10-year risk equal to or greater than 3% for hip fracture, and equal to or greater than 20% for major fracture, you can diagnose osteoporosis. Now, let’s go one step back and check the DXA scan one more time. If the T-score is -2.5 or lower, you can directly make the diagnosis of osteoporosis.

Sources

  1. "ACR Appropriateness Criteria® Osteoporosis and Bone Mineral Density: 2022 Update" J Am Coll Radiol (2022)
  2. "AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE" Endocr Pract (2020)
  3. "Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement" JAMA (2018)
  4. "Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians" Ann Intern Med (2017)
  5. "Secondary Causes of Osteoporosis" Mayo Clinic Proceedings (2002)
  6. "Bone-density testing interval and transition to osteoporosis in older women" N Engl J Med (2012)
  7. "Diagnosis and Management of Osteoporosis" Am Fam Physician (2015)
  8. "The clinician's guide to prevention and treatment of osteoporosis" Osteoporos Int. (2022)
  9. "Osteoporosis: Clinical Evaluation" Endotext (2000)
  10. "Osteoporosis in men" Am Fam Physician (2010)
  11. "Osteoporosis or Low Bone Mass in Older Adults: United States, 2017-2018 Key Findings" Am Fam Physician (2017)
  12. "Diagnostic Tests: Bone mineral density: testing for osteoporosis" Australian Prescriber (2016)